Document is current
Any future updates will be listed below
-
Authors
Schmidt, Mark A.
Gruß, Inga
Davis, James V.
Donald, Judy
McQuarrie, Kelly
Sarnecki, Michal
Doua, Joachim
Pastor, Luis Hernandez
Geurtsen, Jeroen
Valencia, Cristina
Carrió, Elvira
Verstraeten, Thomas
El Khoury, Antoine C.
- License Information
-
More Information
Article History
Received: 17 April 2025
Accepted: 3 September 2025
First Online: 31 October 2025
Declarations
:
: The Kaiser Permanente Northwest Institutional Review Board approved the study (reference number: 1394499-10). The study was performed in accordance with the Declaration of Helsinki. Participants provided verbal consent and were subsequently provided with written information about the purpose of the study and requirements of participation by (e-)mail. Before the start of the interview, consent was reconfirmed. At any time, participants had the right to opt out or withdraw from the study, without their rights or medical care being affected.
: Not applicable.
: During the conduct of this study, MAS, IG, JVD, and JDonald worked for Kaiser Permanente Center for Health Research, which received institutional research grant funding for this study from P95; KM, MS, JDoua, LHP, JG, and ACEK were employed by Janssen Pharmaceutical Company of Johnson & Johnson; and CV, EC, and TV worked for P95, a company that received consulting fees from Johnson & Johnson.
